Equitec Specialists’s Immunogen Inc IMGN Stock Holding History

Equitec Specialists’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,000	Closed	-$4K	–	102
2016 Q4	$4K	Hold	2,000	–	–	﹤0.01%	107
2016 Q3	$5K	Buy	+2,000	New	+$5.82K	﹤0.01%	101

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Equitec Specialists's IMGN Position: Q1 2017 in Review

Equitec Specialists sold out of Immunogen Inc (IMGN) in Q1 2017, closing a stake of 2,000 shares — an estimated $4K sold.

Equitec Specialists first reported a position in IMGN in Q3 2016 and held it in 2 quarters. The position peaked at $5K in Q3 2016. 135 funds tracked by Wall St. Rank hold IMGN as of Q1 2017.

Equitec Specialists reported no remaining Immunogen Inc position as of Q1 2017 after selling out during the quarter.
Equitec Specialists sold 2,000 Immunogen Inc shares in Q1 2017, an estimated $4K.
Equitec Specialists first reported a position in Immunogen Inc in Q3 2016 and held it in 2 quarters.
Equitec Specialists's Immunogen Inc position peaked at $5K in Q3 2016.
135 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2017.

Based on Equitec Specialists's 13F filing for Q1 2017, filed 25 Apr 2017.